Table 1. Comparison of clinical features of families with SLC29A3 mutations from this report and those reported with H syndrome and PHID syndrome.
Clinical diagnosis | Faisalabad histiocytosis | Familial SHML | Familial Rosai Dorfman disease/Faisalabad histiocytosis | H syndrome | Pigmented hypertrichosis with insulin dependent diabetes mellitus syndrome | |
OMIM reference | 602782 | 612391 | ||||
Literature reference | Moynihan et al (1998) | Kismet et al (2005) | Rossbach et al (2005) | Mohlo-Pessach et al (2008) | Cliffe et al (2009) | |
Inheritance | Autosomal recessive | Autosomal recessive | Autosomal recessive | Autosomal recessive | Autosomal recessive | |
Number of kindreds and ethnic origin | 1 (Pakistani) | 1 (Turkish) | 1 (Palestinian) | 10 (9 Arab and one Bulgarian) | 5 (1 North American Caucasian, 1 Indian, 1 Pakistani and 2 Lebanese) | |
Skin | Hyper-pigmentation lower extremities | Hyperpigmented and hypertrichotic patches | Pigmented hypertrichotic skin lesions | |||
Heart | Small ASD (one case) | PS, PDA | ||||
Ear | Sensorineural deafness | Sensorineural deafness | Sensorineural deafness | Sensorineural hearing loss | No deafness | |
Abdomen | Hepatomegaly | Hepatosplenomegaly | Hepatosplenomegaly | |||
Growth | Short stature | Short stature | Short stature | Short stature | Short stature | |
Endocrine | Hypogonadism | GynaeocomastiaHypogonadism | Delayed puberty | |||
Pancreas | Occasional hyperglycaemia | IDDM in >80% of casesSevere pancreatic exocrine deficiency (two cases) | ||||
Eyes | Eyelid swellings due to histiocytic deposits | Rapidly growing orbital mass with SHML histopathology | Uveitis (1/2 cases) | Exophthalmos with normal thyroid function | ||
Hands | Progressive contractures of the fingers | Camptodactyly, flexion contractures of hands | No abnormality | |||
Feet | Progressive contractures of toes | Hallux valgus with fixed flexion contractures of toe joints | ||||
Haematological features | Bone marrow : diverse cytoplasmic inclusions in phagocytes and reticulum cells. | The bone marrow: non-clonal myeloproliferativeProcess. Numerous monocytes and histiocytes and moderate myelofibrosis. | Red cell aplasia due to myelofibrosis in one patient | |||
Lymph nodes | Generalised lymphadenopathy | Cervical, retropharyngeal and submandibular lymphadenopathy | Cervical, submandibular and, bilateral inguinal lymphadenopathy | Cervical, axillary and inguinal lymphadenopathy | ||
Histopathology | Lymph node and eyelid show reactive features with small reactive lymphoid follicles and histiocytes within hyperglycaemiadilated hyperglycaemiasinuses hyperglycaemiaresembling hyperglycaemiaRosai-Dorfman disease | Lymph node: filling of lymph node sinuses with histiocytes, plasma cells and lymphocytes. Histiocytes had a benign appearance, were CD-1a negative but positive for CD68 and S-100. | Lymph node: nodal capsular fibrosis and chronic inflammation, prominent sinus histiocytes. | Skin lesions show polyclonal perivascular lymphohistiocytic infiltration with numerous plasma cells in the dermis and subcutis | ||
Other | Nasal mucosa swellingsContractures of the elbows and ankleProband: invasive ductal carcinoma grade 3 ER negative breast aged 43 years and carcinoma bladder (grade 3 papillary TCC) age 46 years | Intra-uterine fracturesVentriculomegaly with communicating hydrocephalus and right lambdoid suture stenosis with subsequent plagiocephalyPectus carinatum | ||||
SLC29A3 mutations | c.300+1G>A | p.Gly437Argp.Phe103X | p.Gly437Arg | p.Gly427Serp.Gly437Argp.Leu349SerfsX56 | p.Met116Arg; p.Tyr314ThrfsX91p.Gly437Arg; p.Glu444Xp.Thr449Arg |
Clinical details were taken from published reports and unpublished updated information for the three families included in the present study. Previously unreported additional information is shown in bold. Mutation nomenclature used is based on reference sequence NM_018344.4. (Abbreviations: SHML = Sinus Histiocytosis with Massive Lymphadenopathy; IDDM = Insulin dependent diabetes mellitus; ASD = atrial septal defect; PS = Pulmonary stenosis; PDA = patent ductus areteriosis; TCC = transitional cell carcinoma).